Literature DB >> 23344574

Increased biological response to 1,25(OH)(2)D(3) in genetic hypercalciuric stone-forming rats.

Kevin K Frick1, John R Asplin, Murray J Favus, Christopher Culbertson, Nancy S Krieger, David A Bushinsky.   

Abstract

Genetic hypercalciuric stone-forming (GHS) rats, bred to maximize urine (U) calcium (Ca) excretion, have increased intestinal Ca absorption and bone Ca resorption and reduced renal Ca reabsorption, leading to increased UCa compared with the Sprague-Dawley (SD) rats. GHS rats have increased vitamin D receptors (VDR) at each of these sites, with normal levels of 1,25(OH)(2)D(3) (1,25D), indicating that their VDR is undersaturated with 1,25D. We tested the hypothesis that 1,25D would induce a greater increase in UCa in GHS rats by feeding both strains ample Ca and injecting 1,25D (25 ng · 100 g body wt(-1) · day(-1)) or vehicle for 16 days. With 1,25D, UCa in SD increased from 1.7 ± 0.3 mg/day to 24.4 ± 1.2 (Δ = 22.4 ± 1.5) and increased more in GHS from 10.5 ± 0.7 to 41.9 ± 0.7 (Δ = 29.8 ± 1.8; P = 0.003). To determine the mechanism of the greater increase in UCa in GHS rats, we measured kidney RNA expression of components of renal Ca transport. Expression of transient receptor potential vanilloid (TRPV)5 and calbindin D(28K) were increased similarly in SD + 1,25D and GHS + 1,25D. The Na(+)/Ca(2+) exchanger (NCX1) was increased in GHS + 1,25D. Klotho was decreased in SD + 1,25D and GHS + 1,25D. TRPV6 was increased in SD + 1,25D and increased further in GHS + 1,25D. Claudin 14, 16, and 19, Na/K/2Cl transporter (NKCC2), and secretory K channel (ROMK) did not differ between SD + 1,25D and GHS + 1,25D. Increased UCa with 1,25D in GHS exceeded that of SD, indicating that the increased VDR in GHS induces a greater biological response. This increase in UCa, which must come from the intestine and/or bone, must exceed any effect of 1,25D on TRPV6 or NCX1-mediated renal Ca reabsorption.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23344574      PMCID: PMC3602696          DOI: 10.1152/ajprenal.00645.2012

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  97 in total

Review 1.  Molecular aspects of renal tubular handling and regulation of inorganic sulfate.

Authors:  L Beck; C Silve
Journal:  Kidney Int       Date:  2001-03       Impact factor: 10.612

2.  Hyperresponsiveness of vitamin D receptor gene expression to 1,25-dihydroxyvitamin D3. A new characteristic of genetic hypercalciuric stone-forming rats.

Authors:  J Yao; P Kathpalia; D A Bushinsky; M J Favus
Journal:  J Clin Invest       Date:  1998-05-15       Impact factor: 14.808

3.  Trpv6 mediates intestinal calcium absorption during calcium restriction and contributes to bone homeostasis.

Authors:  L Lieben; B S Benn; D Ajibade; I Stockmans; K Moermans; M A Hediger; J B Peng; S Christakos; R Bouillon; G Carmeliet
Journal:  Bone       Date:  2010-04-24       Impact factor: 4.398

4.  Increased sensitivity to 1,25(OH)2D3 in bone from genetic hypercalciuric rats.

Authors:  N S Krieger; V M Stathopoulos; D A Bushinsky
Journal:  Am J Physiol       Date:  1996-07

5.  Vitamin D upregulates expression of ECaC1 mRNA in semicircular canal.

Authors:  Daisuke Yamauchi; Nithya N Raveendran; Satyanarayana R Pondugula; Suresh B Kampalli; Joel D Sanneman; Donald G Harbidge; Daniel C Marcus
Journal:  Biochem Biophys Res Commun       Date:  2005-06-17       Impact factor: 3.575

6.  Kidney claudin-19: localization in distal tubules and collecting ducts and dysregulation in polycystic renal disease.

Authors:  Nikki P Y Lee; Man K Tong; Pauline P Leung; Vivian W Chan; Simon Leung; Po-Chor Tam; Kwok-Wah Chan; Kai-Fai Lee; William S B Yeung; John M Luk
Journal:  FEBS Lett       Date:  2006-01-18       Impact factor: 4.124

7.  Gain-of-function haplotype in the epithelial calcium channel TRPV6 is a risk factor for renal calcium stone formation.

Authors:  Yoshiro Suzuki; Andreas Pasch; Olivier Bonny; Markus G Mohaupt; Matthias A Hediger; Felix J Frey
Journal:  Hum Mol Genet       Date:  2008-02-13       Impact factor: 6.150

8.  The ROMK potassium channel is present in mammalian urinary tract epithelia and muscle.

Authors:  David A Spector; Qing Yang; Leonid Klopouh; Jie Deng; Edward J Weinman; Deborah A Steplock; Rajatsubhra Biswas; Marc F Brazie; Jie Liu; James B Wade
Journal:  Am J Physiol Renal Physiol       Date:  2008-09-17

9.  Aromatase deficiency causes altered expression of molecules critical for calcium reabsorption in the kidneys of female mice *.

Authors:  Orhan K Oz; Asghar Hajibeigi; Kevin Howard; Carolyn L Cummins; Monique van Abel; Rene Jm Bindels; R Ann Word; Makoto Kuro-o; Charles Y C Pak; Joseph E Zerwekh
Journal:  J Bone Miner Res       Date:  2007-12       Impact factor: 6.741

10.  Effect of bolus and divided feeding on urine ions and supersaturation in genetic hypercalciuric stone-forming rats.

Authors:  D A Bushinsky; A C Michalenka; K L Strutz; S Donahue; J R Asplin
Journal:  Kidney Int       Date:  2007-11-28       Impact factor: 10.612

View more
  12 in total

1.  Chlorthalidone Is Superior to Potassium Citrate in Reducing Calcium Phosphate Stones and Increasing Bone Quality in Hypercalciuric Stone-Forming Rats.

Authors:  Nancy S Krieger; John R Asplin; Ignacio Granja; Felix M Ramos; Courtney Flotteron; Luojing Chen; Tong Tong Wu; Marc D Grynpas; David A Bushinsky
Journal:  J Am Soc Nephrol       Date:  2019-05-17       Impact factor: 10.121

2.  Effect of Potassium Citrate on Calcium Phosphate Stones in a Model of Hypercalciuria.

Authors:  Nancy S Krieger; John R Asplin; Kevin K Frick; Ignacio Granja; Christopher D Culbertson; Adeline Ng; Marc D Grynpas; David A Bushinsky
Journal:  J Am Soc Nephrol       Date:  2015-04-08       Impact factor: 10.121

3.  1,25(OH)₂D₃ induces a mineralization defect and loss of bone mineral density in genetic hypercalciuric stone-forming rats.

Authors:  Adeline H Ng; Kevin K Frick; Nancy S Krieger; John R Asplin; Madison Cohen-McFarlane; Christopher D Culbertson; Kelly Kyker-Snowman; Marc D Grynpas; David A Bushinsky
Journal:  Calcif Tissue Int       Date:  2014-01-31       Impact factor: 4.333

4.  Low Sodium Diet Decreases Stone Formation in Genetic Hypercalciuric Stone-Forming Rats.

Authors:  Nancy S Krieger; Marc Grynpas; Amy VandenEynde; John R Asplin; Kevin K Frick; Min Ho Kim; Felix M Ramos; Ignacio Granja; David A Bushinsky
Journal:  Nephron       Date:  2019-02-06       Impact factor: 2.847

Review 5.  Structure and function of the calcium-selective TRP channel TRPV6.

Authors:  Maria V Yelshanskaya; Kirill D Nadezhdin; Maria G Kurnikova; Alexander I Sobolevsky
Journal:  J Physiol       Date:  2020-03-13       Impact factor: 5.182

6.  Persistence of 1,25D-induced hypercalciuria in alendronate-treated genetic hypercalciuric stone-forming rats fed a low-calcium diet.

Authors:  Kevin K Frick; John R Asplin; Christopher D Culbertson; Ignacio Granja; Nancy S Krieger; David A Bushinsky
Journal:  Am J Physiol Renal Physiol       Date:  2014-02-26

Review 7.  Modeling hypercalciuria in the genetic hypercalciuric stone-forming rat.

Authors:  Kevin K Frick; Nancy S Krieger; David A Bushinsky
Journal:  Curr Opin Nephrol Hypertens       Date:  2015-07       Impact factor: 2.894

8.  1,25(OH)₂D₃-enhanced hypercalciuria in genetic hypercalciuric stone-forming rats fed a low-calcium diet.

Authors:  Kevin K Frick; John R Asplin; Nancy S Krieger; Christopher D Culbertson; Daniel M Asplin; David A Bushinsky
Journal:  Am J Physiol Renal Physiol       Date:  2013-08-07

9.  Chlorthalidone with potassium citrate decreases calcium oxalate stones and increases bone quality in genetic hypercalciuric stone-forming rats.

Authors:  Nancy S Krieger; John Asplin; Ignacio Granja; Luojing Chen; Daiana Spataru; Tong Tong Wu; Marc Grynpas; David A Bushinsky
Journal:  Kidney Int       Date:  2021-01-05       Impact factor: 10.612

10.  Demographics and characterization of 10,282 Randall plaque-related kidney stones: a new epidemic?

Authors:  Emmanuel Letavernier; Sophie Vandermeersch; Olivier Traxer; Mohamed Tligui; Laurent Baud; Pierre Ronco; Jean-Philippe Haymann; Michel Daudon
Journal:  Medicine (Baltimore)       Date:  2015-03       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.